Biome Australia Ltd
ASX:BIO
Net Margin
Biome Australia Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
AU |
B
|
Biome Australia Ltd
ASX:BIO
|
92.1m AUD |
2%
|
|
FR |
![]() |
L'Oreal SA
PAR:OR
|
191.8B EUR |
15%
|
|
UK |
![]() |
Unilever PLC
LSE:ULVR
|
114.9B GBP |
9%
|
|
IN |
![]() |
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.4T INR |
17%
|
|
UK |
![]() |
HALEON PLC
LSE:HLN
|
35B GBP |
13%
|
|
US |
![]() |
Estee Lauder Companies Inc
NYSE:EL
|
28.4B USD |
-6%
|
|
DE |
![]() |
Beiersdorf AG
XETRA:BEI
|
23.9B EUR |
9%
|
|
JP |
![]() |
Kao Corp
TSE:4452
|
3T JPY |
7%
|
|
IN |
![]() |
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
13%
|
|
IN |
![]() |
Dabur India Ltd
NSE:DABUR
|
835B INR |
14%
|
|
CA |
![]() |
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
-19%
|
Biome Australia Ltd
Glance View
Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-30. The firm licenses, develops and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products include 22 products marketed under three brands, being Activated Probiotics, Activated Nutrients and Activated X Performance. These products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trials.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Biome Australia Ltd's most recent financial statements, the company has Net Margin of 1.8%.